European Association for Hemophilia and Allied Disorders (EAHAD 2026) 3 - 6 February 2026

Mim8, a novel FVIIIa mimetic bispecific antibody, restores hemostatic thrombin generation ex vivo in patients with acquired hemophilia A

Authors :

A. Briane¹, V. Horvais², J. Graveleau¹, A. Babuty², N. Drillaud², C. Ternisien², M. Trossaert², M. Fouassier²,*

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Rare Blood Disorders

Congress poster

Mim8